DK200201483A - Dermatologisk anvendelse og dermatologisk præparat - Google Patents

Dermatologisk anvendelse og dermatologisk præparat Download PDF

Info

Publication number
DK200201483A
DK200201483A DK200201483A DKPA200201483A DK200201483A DK 200201483 A DK200201483 A DK 200201483A DK 200201483 A DK200201483 A DK 200201483A DK PA200201483 A DKPA200201483 A DK PA200201483A DK 200201483 A DK200201483 A DK 200201483A
Authority
DK
Denmark
Prior art keywords
dermatological
application
preparation
acid
dermatological preparation
Prior art date
Application number
DK200201483A
Other languages
English (en)
Inventor
Heino Pekka
Original Assignee
Ipsat Therapies Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsat Therapies Oy filed Critical Ipsat Therapies Oy
Publication of DK200201483A publication Critical patent/DK200201483A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Description

PATENTKRAV 1. Anvendelse af S.S'.S.S'-tetraiodthyroeddikesyre eller 3,3\5,5'-tetraiodthyropropion-syre til fremstilling af et topisk indgivet medicinsk præparat til behandling af proliferative hudsygdomme. 2. Anvendelse ifølge krav 1, ved hvilken den proliferative hudsygdom er psoriasis. 3. Topisk dermatologisk præparat til behandling af proliferative hudsygdomme indeholdende en terapeutisk effektiv mængde 3,3',5,5'-tetraiodthyroeddikesyre eller 3,3',5,5'-tetraiodthyropropionsyre. 4. Præparat ifølge krav 3 til behandling af psoriasis.
DK200201483A 2000-04-06 2001-02-05 Dermatologisk anvendelse og dermatologisk præparat DK200201483A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20000818A FI107018B (fi) 2000-04-06 2000-04-06 Dermatologinen käyttö ja valmiste
PCT/FI2001/000100 WO2001076589A1 (en) 2000-04-06 2001-02-05 Dermatological use and a dermatological preparation

Publications (1)

Publication Number Publication Date
DK200201483A true DK200201483A (da) 2002-10-03

Family

ID=8558139

Family Applications (1)

Application Number Title Priority Date Filing Date
DK200201483A DK200201483A (da) 2000-04-06 2001-02-05 Dermatologisk anvendelse og dermatologisk præparat

Country Status (14)

Country Link
US (2) US20030144359A1 (da)
EP (1) EP1274416A1 (da)
JP (1) JP2003530349A (da)
AU (1) AU2001235506A1 (da)
CA (1) CA2405425A1 (da)
CH (1) CH695983A5 (da)
DE (1) DE10196025T1 (da)
DK (1) DK200201483A (da)
ES (1) ES2193003B1 (da)
FI (1) FI107018B (da)
GB (1) GB2377380B (da)
NO (1) NO20024810L (da)
SE (1) SE0202886L (da)
WO (1) WO2001076589A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0831769B2 (en) * 1995-06-07 2008-07-23 Lavin, Dr., Thomas N. Novel uses for thyroid hormones or thyroid hormone-like compounds
US8668926B1 (en) 2003-09-15 2014-03-11 Shaker A. Mousa Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
US9198887B2 (en) 2003-09-15 2015-12-01 Nanopharmaceuticals Llc Thyroid hormone analogs and methods of use
AU2004273986B2 (en) * 2003-09-15 2010-04-22 Nanopharmaceuticals Llc Thyroid hormone analogs and methods of use in angiogenesis
US9498536B2 (en) 2005-09-15 2016-11-22 Nanopharmaceuticals Llc Method and composition of thyroid hormone analogues and nanoformulations thereof for treating anti-inflammatory disorders
US10130686B2 (en) 2005-09-15 2018-11-20 Nanopharmaceuticals Llc Method and composition of thyroid hormone analogues and nanoformulations thereof for treating inflammatory disorders
WO2007035612A2 (en) 2005-09-16 2007-03-29 Ordway Research Institute, Inc. Polyphenol conjugates as rgd-binding compounds and methods of use
EP2120913B1 (en) 2006-12-22 2015-01-21 NanoPharmaceuticals LLC Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
US20100159021A1 (en) * 2008-12-23 2010-06-24 Paul Davis Small Molecule Ligands of the Integrin RGD Recognition Site and Methods of Use
WO2010120506A1 (en) 2009-03-31 2010-10-21 Ordway Research Institute, Inc. Combination treatment of cancer with cetuximab and tetrac
WO2010148007A2 (en) 2009-06-17 2010-12-23 Ordway Research Institute, Inc. Nanoparticle and polymer formulations for thyroid hormone, analogs, antagonists, and formulations and uses thereof
US8802240B2 (en) 2011-01-06 2014-08-12 Nanopharmaceuticals Llc Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensitivity and radiosensitivity in tumor or cancer cells
EP3463477A4 (en) 2016-06-07 2020-03-04 NanoPharmaceuticals LLC NON-CLeavable POLYMER CONJUGATED WITH THYROID ANTAGONISTS OF avß3 INTEGRIN
US11351137B2 (en) 2018-04-11 2022-06-07 Nanopharmaceuticals Llc Composition and method for dual targeting in treatment of neuroendocrine tumors
US10328043B1 (en) 2018-04-11 2019-06-25 Nanopharmaceuticals, Llc. Composition and method for dual targeting in treatment of neuroendocrine tumors
US10961204B1 (en) 2020-04-29 2021-03-30 Nanopharmaceuticals Llc Composition of scalable thyrointegrin antagonists with improved blood brain barrier penetration and retention into brain tumors
US11723888B2 (en) 2021-12-09 2023-08-15 Nanopharmaceuticals Llc Polymer conjugated thyrointegrin antagonists

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB859546A (en) * 1956-05-29 1961-01-25 Arthur Alfred Hellbaum Composition for treatment of the skin
US3198702A (en) * 1960-03-17 1965-08-03 Arthur A Hellbaum Method for treating skin burns
CA2184002A1 (en) * 1994-02-23 1995-08-31 Jeffrey M. Blaney Method and compositions for increasing the serum half-life of pharmacologically active agents
US6380255B1 (en) * 1995-06-07 2002-04-30 Karo Bio Ab Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds
EP0831769B2 (en) * 1995-06-07 2008-07-23 Lavin, Dr., Thomas N. Novel uses for thyroid hormones or thyroid hormone-like compounds
HUT75956A (en) * 1995-11-29 1997-05-28 Cyclolab Pharmaceutical composition containing thyroxine
US5951989A (en) * 1997-04-07 1999-09-14 Heymann; Warren R. Method for the treatment of dry skin
GB9828442D0 (en) * 1998-12-24 1999-02-17 Karobio Ab Novel thyroid receptor ligands and method II
JP2002542284A (ja) * 1999-04-26 2002-12-10 ダンフォース，エリオット，ジュニア テトラックの薬学組成物およびその使用方法
US6716877B2 (en) * 2001-01-31 2004-04-06 The Arizona Board Of Regents On Behalf Of The University Of Arizona Method to treat chronic heart failure and/or elevated cholesterol levels

Also Published As

Publication number Publication date
DE10196025T1 (de) 2003-03-13
EP1274416A1 (en) 2003-01-15
US20050272817A1 (en) 2005-12-08
FI107018B (fi) 2001-05-31
CA2405425A1 (en) 2001-10-18
US20030144359A1 (en) 2003-07-31
GB2377380B (en) 2004-07-14
GB2377380A (en) 2003-01-15
CH695983A5 (de) 2006-11-15
GB0222880D0 (en) 2002-11-13
FI20000818A0 (fi) 2000-04-06
SE0202886L (sv) 2002-12-02
JP2003530349A (ja) 2003-10-14
ES2193003B1 (es) 2005-02-01
SE0202886D0 (sv) 2002-10-01
ES2193003A1 (es) 2003-10-16
NO20024810D0 (no) 2002-10-04
WO2001076589A1 (en) 2001-10-18
NO20024810L (no) 2002-12-06
AU2001235506A1 (en) 2001-10-23

Similar Documents

Publication Publication Date Title
DK200201483A (da) Dermatologisk anvendelse og dermatologisk præparat
ATE162399T1 (de) Terfanadin metaboliten und deren optisch reine isomere zur behandlung von allergischen krankheiten
BR9408478A (pt) Composto composição farmacéutica processos de tratmento de uma doença suscetível ao tratamento com agente anti-inflamatório não esteroidal e de tratamento de doenças medidas pela ciclo-oxigenase, sal farmaceuticamente eficaz e uso de um composto
IT8024370A1 (it) Composizione terapeutica di dimetil solfossido e procedimenti per il suo impiego
DE69418601T2 (de) Guanidinderivate mit therapeutischer wirkung
KR960000855A (ko) L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제조성물
PT920865E (pt) Utilizacao de ""norastemizole"" para o tratamento de disturbios alergicos
PL330768A1 (en) Perpetration for use in therapy and prophylactics of dermatological diseases
WO2001012214A3 (en) MYCOPHENOLATE MOFETIL IN ASSOCIATION WITH PEG-IFN-$g(a)
DK1131063T3 (da) Hyperforinsalve eller -creme
KR960010003A (ko) L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제 조성물
MA26726A1 (fr) Composition pharmaceutique de resorcinol, et procede pour sa preparation
KR880005920A (ko) 인체의 백혈구 인터페론 조성물과 피부 치료법
ATE271872T1 (de) Topische carbamazepin-formulierungen und deren verwendung
IT1211103B (it) Sostanza medicamentosa ad impiego topico per il trattamento delle affezioni provocate dalla seborrea sul cuoio capelluto umano.
ITRM910756A0 (it) Miscela di biofarmaci somministrabile per fleboterapia nel trattamentodelle patologie neuro-psico-somatiche e organico-vascolari, in particolare arteriopatie diabetiche e nicotiniche, cardiopatie ischemiche, tossicodipendenze, psoriasi
RU94038468A (ru) Способ в.ф.можаровского комплексного этиологического лечения псориаза противовирусным и противомикробными препаратами "ликвацид", "тринол", "трисолид" и "тротицид"
ITMI992566A0 (it) Composizione dermatologica per il trattamento topico di malattie cutan ee
NO20006260L (no) Farmasöytisk sammensetning på basisen av erytromycin- fettsyresalter til topisk behandling av hudsykdommer
ATE90560T1 (de) Verwendung einer hydroxyoctadecadiensaeure, deren zur ketoform oxidierte saeure sowie deren derivate zur therapie oestrogenabhaengiger krankheiten, sowie pharmazeutische zusammensetzungen, die diese enthalten.
BG100Y1 (en) Composition for the treatment of hemorrhoids and skin diseases

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment